Frank Vom Dorp

Duisburg, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Immune checkpoint inhibition plus Bacillus Calmette-Guerin (BCG) therapy in BCG-naive high-risk non-muscle-invasive bladder cancer: a critical review in the context of current evidence

Immune checkpoint inhibition plus Bacillus Calmette-Guerin (BCG) therapy in BCG-naive high-risk non-muscle-invasive bladder cancer: a critical review in the context of current evidence

Journal: Urologie (Heidelberg, Germany)

Published: May 08, 2026

Self-critical, multicenter analysis of treatment and coding quality using the example of nephroureterectomy on the basis of billing data

Self-critical, multicenter analysis of treatment and coding quality using the example of nephroureterectomy on the basis of billing data

Journal: Urologie (Heidelberg, Germany)

Published: July 25, 2025

Validation of a 3D-printed robot-assisted partial nephrectomy training model.

Validation of a 3D-printed robot-assisted partial nephrectomy training model.

Journal: BJUI compass

Published: April 09, 2023

Chronic Kidney Disease and Pregnancy. Guideline of the DGGG, OEGGG, DGfN (S2k Level, AWMF Registry No. 015 - 090).

Chronic Kidney Disease and Pregnancy. Guideline of the DGGG, OEGGG, DGfN (S2k Level, AWMF Registry No. 015 - 090).

Journal: Geburtshilfe und Frauenheilkunde

Published: January 28, 2022

Organ preservation in cancer of the upper urinary tract

Organ preservation in cancer of the upper urinary tract

Journal: Der Urologe. Ausg. A

Published: January 17, 2019

Erratum to: How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases

Erratum to: How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases

Journal: Der Urologe. Ausg. A

Published: June 30, 2018

Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer.

Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer.

Journal: The Prostate

Published: February 01, 2016

Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis.

Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis.

Journal: The Journal of urology

Published: November 28, 2015

Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.

Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.

Journal: International urology and nephrology

Published: October 26, 2015

Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer.

Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer.

Journal: The Journal of urology

Published: October 11, 2015

Nonmuscle-invasive bladder cancer

Nonmuscle-invasive bladder cancer

Journal: Der Urologe. Ausg. A

Published: April 22, 2015

Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study.

Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study.

Journal: The Journal of urology

Published: April 13, 2015

Showing 1-12 of 36

Last Updated: 09/26/2026